Smiths Group’s pre-tax profit jumps nearly 100% in fiscal H1

Smiths Group plc (LON: SMIN) said on Friday that its pre-tax profit posted a close to 100% growth in the fiscal first half. The company also expressed confidence that its full-year financial performance will remain in line with market expectations. Chief Executive Andy Reynolds Smith commented on the financial update on Friday and said:

“While economic uncertainty remains, the Group is confident of meeting market expectations for the full year and delivering long-term sustainable value.”

Smiths Group shares that you can learn to buy online here jumped a little under 2% in premarket trading on Friday and gained another 3% in the next hour. The stock is now trading at a per-share price of £15.32. In comparison, Smiths Group had started the year at £15.45 per share.

Smiths Group reports £1.15 billion of revenue

Smiths Group reported £84 million of pre-tax profit in the six months that concluded on 31^st January. In the comparable period of last year, its pre-tax profit was capped at a much lower £46 million.

The engineering company said that it generated £1.15 billion of revenue in H1. In comparison, its revenue stood at a higher £1.24 billion in the same period last year. Smiths noted £166 million of headline operating profit that topped analysts’ forecast of £151 million.

In separate news from the United Kingdom, AstraZeneca said on Friday that its new research in collaboration with Oxford University will study the immune responses of a nasal administration of its COVID-19 vaccine.

Smiths Group declares 11.7 pence per share of an interim dividend

On the back of hawkish performance, Smiths Group declared 11.7 pence per share of an interim dividend on Friday versus the year-ago figure of 11.0 pence per share. In an earlier report published in November, Smiths Group had recorded a 2% decline in its first-quarter underlying revenue.

The British multinational opted for restructuring and announced job cuts in 2020 to cushion the economic blow from the ongoing Coronavirus pandemic that has so far infected more than 4.3 million people in the United Kingdom and caused over 126 thousand deaths. The global health crisis also made the company separate its medical unit.

Smiths Group performed fairly downbeat in the stock market last year with an annual gain of more than 10%. At the time of writing, it is valued at £6.08 billion and has a price to earnings ratio of 91.46.